Stay updated on AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov record is displayed with the study’s design, eligibility criteria, outcomes, results-related dates, and study documents. It also states that the AVP-786 program was discontinued and the study was terminated.SummaryDifference93%

- Check8 days agoChange DetectedThe site footer now identifies the release as v3.8.0 instead of v3.7.2. The study record remains unavailable and displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedA 403 Forbidden error is shown, replacing the usual study details and navigation on the page. This indicates an access issue or site error rather than a content update.SummaryDifference0.5%

Stay in the know with updates to AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.